← ANALYSTS · TIPRANKS
Derek Archila · Wells Fargo
Hits
58%
279 of 483 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+22.7%
Over a year after the rating, TipRanks’ measure
Our companies rated now
27
Buy / hold / sell: 22 / 5 / 0
Upside of the analyst’s targets
+200.6%
Average over 27 current targets, to the last price
The market’s answer to the ratings
−1.4%
Day-0 move against SPY in the rating’s direction, average over 13 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 15on TipRanks 07:45 | CLDXIWMCelldex · $2.3B | Reiterated | Buy | $72.00 | +161.5% | +3.6%next day −3.7% | ↗ |
| Oct 15on TipRanks 07:36 | KYMRIWMKymera Therapeutics · $9.0B | Reiterated | Buy | $151 | +44.1% | +0.9%next day −2.0% | ↗ |
| Oct 15on TipRanks 07:30 | NTLAIWMIntellia Therapeutics · $1.6B | Reiterated | Hold | $15.00 | +31.3% | −1.1%next day +1.8% | ↗ |
| Oct 15on TipRanks 07:26 | INCYSPYIncyte · $23.0B | Reiterated | Hold | $128 | +13.2% | +1.2%next day +0.9% | ↗ |
| Oct 14on TipRanks 07:05 | ALNYQQQAlnylam Pharma · $31.3B | Assigned | Hold | $256 → $253−1.2% | +9.1% | +1.4%next day +4.0% | ↗ |
| Oct 14on TipRanks 06:50 | VRDNIWMViridian Therapeutics · $2.2B | Assigned | Buy | $31.00 | +62.9% | +2.0%next day +6.1% | ↗ |
| Oct 14on TipRanks 06:50 | ARGXArgenx Se · $51.7B | Assigned | Buy | $1,355 → $1,356+0.1% | +65.5% | +3.0%next day +3.1% | ↗ |
| Oct 12on TipRanks Oct 13 05:30 | INCYSPYIncyte · $23.0B | Reiterated | Hold | $128 | +13.2% | −1.2%next day −2.4% | ↗ |
| Oct 12on TipRanks 17:45 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Reiterated | Buy | $62.00 → $70.00+12.9% | +103.1% | −6.9%next day +8.8% | ↗ |
| Oct 8on TipRanks Oct 9 05:50 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $1,415 → $1,355−4.2% | +65.4% | −11.4%next day +0.2% · 5 days +3.7% | ↗ |
| Oct 8on TipRanks Oct 9 05:50 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Reiterated | Buy | $55.00 → $62.00+12.7% | +79.9% | +5.1%next day −1.1% · 5 days +12.9% | ↗ |
| Oct 1on TipRanks 06:50 | INCYSPYIncyte · $23.0B | Assigned | Hold | $116 → $128+10.3% | +13.2% | −3.6%next day −2.3% · 5 days −5.0% | ↗ |
| Sep 30on TipRanks Oct 1 05:30 | QTTBQ32 Bio · $246M | Reiterated | Buy | $59.00 | +684.6% | −13.0%next day −0.4% · 5 days −5.3% | ↗ |
| Sep 25on TipRanks 05:30 | KYTXIWMKyverna Therapeutics, Inc. · $369M | Reiterated | Buy | $33.00 | +482.0% | −3.1%next day +0.9% · 5 days −8.4% | ↗ |
| Sep 23on TipRanks 06:14 | CLDXIWMCelldex · $2.3B | Reiterated | Buy | $72.00 | +161.5% | −6.4%next day +1.2% · 5 days +4.8% | ↗ |
| Sep 21on TipRanks 10:00 | ALXOIWMALX Oncology Holdings · $138M | Reiterated | Buy | $5.00 | +371.7% | −3.9%next day −3.6% · 5 days −15.2% | ↗ |
| Sep 16on TipRanks 06:35 | IRONIWMDisc Medicine · $2.2B | Assigned | Buy | $79.00 → $86.00+8.9% | +51.3% | +2.3%next day −0.2% · 5 days −5.7% | ↗ |
| Sep 10on TipRanks Sep 9 11:10 | PYXSPyxis Oncology · $240M | Reiterated | Buy | $12.00 → $19.00+58.3% | +1,031.0% | −12.6%next day −2.7% · 5 days −0.1% | ↗ |
| Sep 9on TipRanks 14:00 | SEPNIWMSepterna, Inc. · $1.7B | Reiterated | Buy | $50.00 | +37.6% | +2.1%next day 0.0% · 5 days +2.3% | ↗ |
| Sep 9on TipRanks 13:15 | ALMSIWMAlumis Inc. · $842M | Reiterated | Buy | $25.00 | +308.5% | −6.9%next day +1.6% · 5 days −17.9% | ↗ |
| Sep 9on TipRanks 07:35 | XFORIWMX4 Pharmaceuticals · $262M | Reiterated | Buy | $11.00 | +324.7% | +3.2%next day −5.0% · 5 days −1.4% | ↗ |
| Sep 1on TipRanks 19:10 | NRIXIWMNurix Therapeutics · $2.7B | Reiterated | Hold | $25.00 | +2.4% | −1.3%next day −3.0% · 5 days +0.9% | ↗ |
| Aug 27on TipRanks 07:15 | KYMRIWMKymera Therapeutics · $9.0B | Assigned | Buy | $116 → $151+30.2% | +44.1% | −4.9%next day −1.5% · 5 days −2.7% | ↗ |
| Aug 26on TipRanks 06:50 | ARGXArgenx Se · $51.7B | Assigned | Buy | $1,350 → $1,415+4.8% | +72.7% | +2.7%next day +0.5% · 5 days +0.9% | ↗ |
| Aug 14on TipRanks 06:55 | ASNDAscendis Pharma · $13.9B | Reiterated | Buy | $326 | +44.7% | +1.1%next day 0.0% · 5 days +3.3% | ↗ |
| Aug 13on TipRanks 07:00 | ANNXIWMAnnexon Biosciences · $682M | Reiterated | Buy | $27.00 | +691.8% | −2.0%next day +0.8% · 5 days +0.4% | ↗ |
| Aug 12on TipRanks 06:55 | CCCCIWMC4 Therapeutics · $321M | Assigned | Buy | $10.00 | +261.7% | +0.5%next day +3.9% · 5 days +8.4% | ↗ |
| Aug 11on TipRanks 06:55 | BBIOBridgeBio Pharma · $12.4B | Reiterated | Buy | $98.00 → $102+4.1% | +53.6% | −0.8%next day −0.1% · 5 days −0.5% | ↗ |
| Aug 6on TipRanks 09:50 | INCYSPYIncyte · $23.0B | Reiterated | Hold | $116 | +2.6% | −1.0%next day +1.2% · 5 days +0.6% | ↗ |
| Aug 6on TipRanks 07:11 | QTTBQ32 Bio · $246M | Reiterated | Buy | $66.00 → $59.00−10.6% | +684.6% | −1.6%next day −4.3% · 5 days −6.3% | ↗ |
| Aug 5on TipRanks Aug 4 13:27 | ARVNIWMArvinas Holding Company · $468M | Downgrade | Hold | $15.00 → $11.00−26.7% | +57.8% | +9.9%next day −6.5% · 5 days 0.0% | ↗ |
| Aug 4on TipRanks 07:51 | ORICIWMOric Pharmaceuticals · $1.3B | Reiterated | Buy | $25.00 | +102.4% | +25.3%next day −3.8% · 5 days +2.0% | ↗ |
| Jul 28on TipRanks 03:35 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Reiterated | Buy | $30.00 → $55.00+83.3% | +59.6% | −0.7%next day +1.6% · 5 days +5.8% | ↗ |
| Jul 20on TipRanks 05:50 | VRDNIWMViridian Therapeutics · $2.2B | Assigned | Buy | $31.00 | +62.9% | +3.1%next day +2.5% · 5 days +6.5% | ↗ |
| Jul 16on TipRanks 06:55 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Assigned | Buy | $155 | +79.9% | −2.7%next day +1.5% · 5 days −1.6% | ↗ |
| Jun 24on TipRanks 06:30 | GLUEIWMMonte Rosa Therapeutics · $863M | Assigned | Buy | $29.00 | +197.7% | +0.7%next day +3.7% · 5 days +13.5% | ↗ |
| May 21on TipRanks 05:10 | IMVTIWMImmunovant · $5.8B | Reiterated | Buy | $45.00 | +68.4% | −4.2%next day −0.3% · 5 days −4.3% | ↗ |
| Dec 16on TipRanks Dec 17 10:55 | ANABIWMAnaptysBio · $1.5B | Reiterated | Buy | $81.00 | +73.8% | −0.9%next day +2.6% · 5 days +9.5% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗